MedPath

A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)

Not Applicable
Conditions
Colon polyp
Registration Number
JPRN-UMIN000021947
Lead Sponsor
ational Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1)Plt is less than 50000/mm3 2)Patients who undergo hemodialysis 3)Woman who has a possibility of pregnancy or is during pregnancy 4)Impossible to suspend to one-antiplatelet medication. 5)The attending physician has determined that it is difficult to entry

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath